Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz PharmaGlobeNewsWire • 12/22/25
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens BermanPRNewsWire • 12/17/25
Alvotech Successfully Places USD 108 Million Senior Unsecured Convertible Bonds in a Significantly Oversubscribed OfferingGlobeNewsWire • 12/17/25
Alvotech (ALVO) Discusses Launch of $125 Million Commercial Bond Offering and Business Update TranscriptSeeking Alpha • 12/16/25
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVONewsfile Corp • 12/14/25
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVOPRNewsWire • 12/11/25
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVONewsfile Corp • 12/10/25
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVONewsfile Corp • 12/07/25
Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation – ALVOBusiness Wire • 12/04/25
Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva® (denosumab) in the European Economic AreaGlobeNewsWire • 11/24/25
Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab)GlobeNewsWire • 11/20/25
ALVO ALERT: Levi & Korsinsky Investigates Alvotech for Possible Securities Fraud ViolationsNewsfile Corp • 11/13/25
Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business UpdateGlobeNewsWire • 11/12/25
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Alvotech (NASDAQ: ALVO) and Encourages Investors with Substantial Losses to Contact the FirmPRNewsWire • 11/11/25
Scott+Scott Attorneys at Law LLP Reminds Investors of Its Investigation into Alvotech (NASDAQ: ALVO)GlobeNewsWire • 11/10/25
ALVOTECH ALERT: Bragar Eagel & Squire, P.C. is Investigating Alvotech on Behalf of Alvotech Stockholders and Encourages Investors to Contact the FirmGlobeNewsWire • 11/07/25
Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation into Alvotech (NASDAQ: ALVO)GlobeNewsWire • 11/06/25